Colgate-Palmolive (NYSE:CL) Shares Acquired by Czech National Bank

Czech National Bank raised its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 6.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 166,449 shares of the company's stock after acquiring an additional 10,106 shares during the period. Czech National Bank's holdings in Colgate-Palmolive were worth $17,279,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. D L Carlson Investment Group Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter valued at $3,269,000. Diversify Advisory Services LLC acquired a new stake in Colgate-Palmolive during the first quarter worth about $911,000. TD Asset Management Inc raised its position in Colgate-Palmolive by 2.4% during the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company's stock valued at $103,969,000 after acquiring an additional 26,987 shares in the last quarter. Empowered Funds LLC lifted its holdings in Colgate-Palmolive by 277.3% in the first quarter. Empowered Funds LLC now owns 33,082 shares of the company's stock valued at $2,979,000 after acquiring an additional 24,314 shares during the period. Finally, M&G Plc purchased a new stake in Colgate-Palmolive in the 1st quarter worth approximately $3,812,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the sale, the insider now owns 13,942 shares of the company's stock, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 over the last ninety days. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Trading Down 0.9 %

CL traded down $0.93 during trading hours on Friday, reaching $99.04. The company's stock had a trading volume of 6,030,553 shares, compared to its average volume of 4,348,780. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The stock has a market cap of $81.26 billion, a PE ratio of 31.34, a P/E/G ratio of 3.62 and a beta of 0.40. The business's 50-day moving average is $103.65 and its 200-day moving average is $96.76.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company's quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the company earned $0.77 EPS. As a group, equities research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is 63.29%.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CL. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lowered their price target for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a research report on Thursday, August 1st. Sanford C. Bernstein lifted their price target on Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. Morgan Stanley raised their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an "overweight" rating in a report on Monday, July 29th. Finally, BNP Paribas began coverage on Colgate-Palmolive in a research note on Monday, June 24th. They set an "outperform" rating and a $109.00 target price for the company. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $104.74.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.